Applied Molecular Transport Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Shawn Cross
Chief Executive Officer (CEO)
US$1.7m
Compensación total
| Porcentaje del salario del CEO | 27.7% |
| Permanencia del CEO | less than a year |
| Participación del CEO | 0.2% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 2.1yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Mar 07
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Nov 13Applied Molecular Transport GAAP EPS of -$0.93
Aug 04Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky
Jul 27Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data
Jul 05Applied Molecular: Interesting Drug Delivery Approach For The GI Tract
May 03We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Apr 28We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Jan 08We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Aug 29Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans
Apr 05Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?
Feb 11Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Dec 21Applied Molecular Transport reports Q3 results
Nov 12Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$75m |
| Jun 30 2023 | n/a | n/a | -US$93m |
| Mar 31 2023 | n/a | n/a | -US$112m |
| Dec 31 2022 | US$2m | US$476k | -US$126m |
| Sep 30 2022 | n/a | n/a | -US$134m |
| Jun 30 2022 | n/a | n/a | -US$135m |
| Mar 31 2022 | n/a | n/a | -US$122m |
| Dec 31 2021 | US$3m | US$410k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$89m |
| Jun 30 2021 | n/a | n/a | -US$80m |
| Mar 31 2021 | n/a | n/a | -US$72m |
| Dec 31 2020 | US$2m | US$311k | -US$67m |
Compensación vs. Mercado: Shawn($USD1.72M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD738.70K).
Compensación vs. Ingresos: Shawnha sido coherente con los resultados de la empresa en el último año.
CEO
Shawn Cross (55 yo)
less than a year
Permanencia
US$1,717,813
Compensación
Mr. Shawn M. Cross serves as Managing Director of Healthcare Investment Banking Group at Citizens JMP Securities, LLC (formerly known as JMP Securities LLC). He was Managing Director and Co-Head Healthcare...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Chairman | less than a year | US$1.72m | 0.17% $ 18.3k | |
| Co-Founder & Director | 7.1yrs | US$3.55m | 9.77% $ 1.1m | |
| Independent Director | 1.8yrs | US$394.26k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 1.9yrs | US$429.94k | 0% $ 0 | |
| Independent Director | 7.1yrs | US$90.28k | 0.51% $ 55.9k | |
| Lead Independent Director | 2.3yrs | US$102.84k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
2.1yrs
Permanencia media
57yo
Promedio de edad
Junta con experiencia: AMTIno se consideran experimentados ( 2.1 años de permanencia media), lo que sugiere un nuevo consejo.